SCHEMBL6002123

SCHEMBL6002123

C=CCNc1[c]cc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
KMT2A Q03164 3/20 0.39
RAB9A P51151 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.39
MAPT P10636 2/20 0.39
NFKB1 P19838 2/20 0.39
NFKB2 Q00653 2/20 0.39
RELA Q04206 2/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 5/20 0.36
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
LMNA P02545 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HTT P42858 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2997661 0.75 LMNA (0.34) KMT2ARAB9AMEN1NPC1MAPT
SCHEMBL4598425 0.73 HPGD (0.37) SMN1; SMN2KMT2ARAB9ACYP1A2CYP3A4
SCHEMBL4243384 0.70 CA12 (0.55) SMN1; SMN2KMT2ARAB9ACYP1A2CYP3A4
SCHEMBL168718 0.69 ALDH1A1 (0.38) SMN1; SMN2KMT2ARAB9ACYP1A2MEN1
SCHEMBL14775163 0.67
SCHEMBL15009520 0.65 NPC1 (0.45) SMN1; SMN2KMT2ARAB9AMEN1NPC1
SCHEMBL28995903 0.63 ALDH1A1 (0.33) HPGDALDH1A1L3MBTL1LMNAKDM4E
SCHEMBL16193564 0.63
SCHEMBL8547704 0.63 HCAR3 (0.41) SMN1; SMN2KMT2ARAB9AMEN1MAPT
SCHEMBL15067892 0.63 TSHR (0.41) SMN1; SMN2KMT2AMEN1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1926143-A Tricyclic benzazepine * derivatives as squalene synthase inhibitors for the treatment of cardiovascular diseases BAYER HEALTHCARE AG (DE) 2007-03-07 CN disclosed
EP-1706413-A1 TRICYCLIC BENZAZEPINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS USED FOR THE TREATMENT OF CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2006-10-04 EP disclosed
WO-2005068472-A1 TRICYCLIC BENZAZEPINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS USED FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-07-28 WO disclosed